Daniel P. Gold
2021
In 2021, Daniel P. Gold earned a total compensation of $2.9M as President, Chief Executive Officer & Director at MEI Pharma, a 31% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $348,075 |
|---|---|
| Option Awards | $1,638,800 |
| Salary | $682,500 |
| Stock Awards | $279,200 |
| Total | $2,948,575 |
Gold received $1.6M in option awards, accounting for 56% of the total pay in 2021.
Gold also received $348.1K in non-equity incentive plan, $682.5K in salary and $279.2K in stock awards.
Rankings
In 2021, Daniel P. Gold's compensation ranked 4,497th out of 12,405 executives tracked by ExecPay. In other words, Gold earned more than 63.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,497 out of 12,405 | 64th |
Division Manufacturing | 1,852 out of 5,494 | 66th |
Major group Chemicals And Allied Products | 770 out of 2,369 | 68th |
Industry group Drugs | 685 out of 2,090 | 67th |
Industry Pharmaceutical Preparations | 488 out of 1,537 | 68th |
Source: SEC filing on October 28, 2021.
Gold's colleagues
We found four more compensation records of executives who worked with Daniel P. Gold at MEI Pharma in 2021.